Literature DB >> 9215219

Relative contributions of incidence and survival to increasing prevalence of adult-onset diabetes mellitus: a population-based study.

C L Leibson1, P C O'Brien, E Atkinson, P J Palumbo, L J Melton.   

Abstract

This population-based retrospective study investigates temporal trends in adult-onset diabetes mellitus prevalence, incidence, and survival. The complete community-based medical records, including laboratory results, of all Rochester, Minnesota, residents with a clinical diagnosis of diabetes or diabetes-like condition were reviewed to identify incidence cases aged 30 years or more from 1945 to 1989 (n = 1,847) and prevalence cases aged 45 years or more on January 1, 1970 (n = 465), January 1, 1980 (n = 689), or January 1, 1990 (n = 973). Glucose values and case definitions were standardized throughout. Observed 10-year survival for 1970 and 1980 prevalence cases was compared with that expected for Minnesota white populations in 1970 and 1980, respectively. Age-adjusted prevalence rose 65% for men and 37% for women between 1970 and 1990. There were marked differences among prevalence groups in treatment type, the proportion diagnosed using glucose tolerance tests, and the proportion categorized as obese. Relative survival for 1980 prevalence cases was not greater than that for 1970 prevalence cases. Age-adjusted incidence rates rose 47% for men and 26% for women between 1960 and 1965 and 1985 and 1989. These findings emphasize the need for heightened surveillance and intervention to reduce the burden of illness from adult-onset diabetes mellitus in the population.

Entities:  

Mesh:

Year:  1997        PMID: 9215219     DOI: 10.1093/oxfordjournals.aje.a009187

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  26 in total

1.  Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996.

Authors:  J Feinglass; J L Brown; A LoSasso; M W Sohn; L M Manheim; S J Shah; W H Pearce
Journal:  Am J Public Health       Date:  1999-08       Impact factor: 9.308

2.  A comparison of phenotype definitions for diabetes mellitus.

Authors:  Rachel L Richesson; Shelley A Rusincovitch; Douglas Wixted; Bryan C Batch; Mark N Feinglos; Marie Lynn Miranda; W Ed Hammond; Robert M Califf; Susan E Spratt
Journal:  J Am Med Inform Assoc       Date:  2013-09-11       Impact factor: 4.497

3.  Secular trends and educational differences in the incidence of type 2 diabetes in Finland, 1972-2007.

Authors:  Marian Abouzeid; Katja Wikström; Markku Peltonen; Jaana Lindström; Katja Borodulin; Ossi Rahkonen; Tiina Laatikainen
Journal:  Eur J Epidemiol       Date:  2015-04-03       Impact factor: 8.082

4.  Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality?

Authors:  J M M Evans; K N Barnett; S A Ogston; A D Morris
Journal:  Diabetologia       Date:  2007-01-16       Impact factor: 10.122

5.  Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features.

Authors:  Farid H Mahmud; Joseph A Murray; Yogish C Kudva; Alan R Zinsmeister; Ross A Dierkhising; Brian D Lahr; Peter J Dyck; Robert A Kyle; Mounif El-Youssef; Lawrence J Burgart; Carol T Van Dyke; Deanna L Brogan; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2005-11       Impact factor: 7.616

6.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

7.  Fracture risk in type 2 diabetes: update of a population-based study.

Authors:  L Joseph Melton; Cynthia L Leibson; Sara J Achenbach; Terry M Therneau; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

Review 8.  The heart failure epidemic.

Authors:  Véronique L Roger
Journal:  Int J Environ Res Public Health       Date:  2010-04-19       Impact factor: 3.390

Review 9.  Preconception care of women with diabetes: a review of current guideline recommendations.

Authors:  Maimunah Mahmud; Danielle Mazza
Journal:  BMC Womens Health       Date:  2010-01-31       Impact factor: 2.809

10.  Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective.

Authors:  Werner A Scherbaum; Gordon Goodall; Katrina M Erny-Albrecht; Massimo Massi-Benedetti; Erland Erdmann; William J Valentine
Journal:  Cost Eff Resour Alloc       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.